Cancer Related-RisksNCT00588211
Measurement of Cancer-Related Risk Perception in Smokers
An observational study of Cancer Related-Risks and Risk Perception, run by Memorial Sloan Kettering Cancer Center at 4 sites in United States.
Trial summary
The purpose of this study is to develop an accurate way of measuring people's thoughts about cancer risk. The researchers at the Queens Hospital Center, Memorial Sloan-Kettering Cancer Center and Adelphi University are working together to design a new measure. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Cancer Related-Risks, Risk Perception, Survey
- What is being tested?
- Interviews, focus group and Survey
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 1,514 participants
- Where
- 4 sitesUnited States
- Study dates
- Sep 2001to 13 Sep 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: * clinic patients Queens Hospital Center * students participants from Adelphi University
Who may be able to join
- Subject must be >= to 18 years of age
- For recruitment at Adelphi University: Speak English
- For recruitment at Queens Hospital Center: Speak English
- For recruitment at Queens Hospital Center: Must be a Queens Hospital Center Patient
Who cannot join
- Patients who have a history of colorectal cancer at the Queens Hospital Center
- Patients who cannot give informed consent
Trial locations and contacts
4 sites in 1 country.
United States4 sites
Queens Hospital Center
Jamaica, New York, 11432
New York University, College of Dentistry
New York, New York, 10010
Memorial Sloan-Kettering Cancer Center
New York, New York, 10065
Adelphi University
New York, New York, 11013
About this study
The purpose of this study is to develop an accurate way of measuring people's thoughts about cancer risk. The researchers at the Queens Hospital Center, Memorial Sloan-Kettering Cancer Center and Adelphi University are working together to design a new measure. Findings from this study will help us find new ways to help people avoid cancer.
Read the detailed description
The goal of the study is to develop and provide initial evidence for the reliability and validity of a measure of cancer-related risk perception. As such, the primary outcomes of the study will be initial construct validity (convergent validity and discriminant validity) of the proposed scale as evidenced by correlations of this test with other tests that vary in the degree of association to the proposed construct of cancer-related risk perception. It is anticipated that the cancer-related risk perception scale will correlate most highly (.50-.60) with measures of tobacco and environmental risk exposures, readiness to quit smoking, and family cancer history.
- Conditions
- Cancer Related-Risks, Risk Perception, Survey, Focus Group
- Being tested
- Interviews, focus group, Survey
- Keywords
- Cancer related-Risks, Risk Perception, Survey, Focus Group, Smoking cessation, tobacco
- Medical subject headings
- Smoking Cessation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
InterviewsBehavioural
45-minute individual interviews after the conclusion of their dental appointment
focus groupBehavioural
A focus group of the preliminary cancer-related risk perception item pool.
SurveyBehavioural
Quantitative item analysis of the final item pool.
SurveyBehavioural
A second confirmatory factor analysis.
| Study group | Role | What they receive |
|---|---|---|
| 1 | We will recruit fifteen New York University College of Dentistry (NYUCD) clinic patients who report current tobacco use. Receives: Behavioral: Interviews | |
| 2 | Second, we will recruit thirty dental clinic smokers (10 per day for 3 days) from the NYUCD waiting room. Receives: Behavioral: focus group | |
| 3 | Third, we will survey 200 student participants from Adelphi University. Receives: Behavioral: Survey | |
| 4 | Queens Hospital Center with 800 patients. Receives: Behavioral: Survey |
What is being measured
The primary outcome is the main question the study is designed to answer.
Develop a comprehensive "blueprint," or description of the cancer-related risk perception construct; to use it to generate a cancer-related risk perception item pool; conduct an analysis of the generated items
Measured: 3 years
Secondary outcomes (1)
to establish initial evidence for scale reliability and validity
Measured: 3 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Jan 2008 (estimated)
- Study startSep 2001
- Primary completion13 Sep 2022
- Study completion13 Sep 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cancer Related-RisksStudies of the same condition, open and under way.
- More trials run by Memorial Sloan Kettering Cancer CenterThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 1,514 participants (actual)
Sponsor and investigators
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Sponsor type
- University, hospital or other
- Collaborators
- National Cancer Institute (NCI), Adelphi University, Queen's Hospital Center
- Responsible party
- Sponsor
- Investigators
- Jennifer L Hay, PhD, Principal investigator, Memorial Sloan Kettering Cancer Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00588211
- Sponsor's protocol ID
- 01-121
- Other IDs
- CA93182
- Status last verified
- Sep 2022
- First submitted
- 24 Dec 2007
- Last updated
- 16 Sep 2022
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 16 Sep 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Measurement of Cancer-Related Risk Perception in Smokers
- ClinicalTrials.gov ID
- NCT00588211
- Acronym / sponsor ID
- 01-121
- Conditions
- Cancer Related-Risks, Risk Perception, Survey, Focus Group
- Keywords
- Cancer related-Risks, Risk Perception, Survey, Focus Group, Smoking cessation, tobacco
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1,514 participants (actual)
- Lead sponsor
- Memorial Sloan Kettering Cancer CenterUniversity, hospital or other
- Collaborators
- National Cancer Institute (NCI), Adelphi University, Queen's Hospital Center
- Study start
- Sep 2001
- Primary completion
- 13 Sep 2022 (actual)
- Study completion
- 13 Sep 2022 (actual)
- First posted
- 8 Jan 2008 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to develop an accurate way of measuring people's thoughts about cancer risk. The researchers at the Queens Hospital Center, Memorial Sloan-Kettering Cancer Center and Adelphi University are working together to design a new measure. Findings from this study will help us find new ways to help people avoid cancer.
Detailed description
The goal of the study is to develop and provide initial evidence for the reliability and validity of a measure of cancer-related risk perception. As such, the primary outcomes of the study will be initial construct validity (convergent validity and discriminant validity) of the proposed scale as evidenced by correlations of this test with other tests that vary in the degree of association to the proposed construct of cancer-related risk perception. It is anticipated that the cancer-related risk perception scale will correlate most highly (.50-.60) with measures of tobacco and environmental risk exposures, readiness to quit smoking, and family cancer history.
Study design
- Observational model
- Other
- Time perspective
- Prospective
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| 1 | – | Behavioral: InterviewsWe will recruit fifteen New York University College of Dentistry (NYUCD) clinic patients who report current tobacco use. |
| 2 | – | Behavioral: focus groupSecond, we will recruit thirty dental clinic smokers (10 per day for 3 days) from the NYUCD waiting room. |
| 3 | – | Behavioral: SurveyThird, we will survey 200 student participants from Adelphi University. |
| 4 | – | Behavioral: SurveyQueens Hospital Center with 800 patients. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- * clinic patients Queens Hospital Center * students participants from Adelphi University
Key inclusion criteria (4 listed)
- Subject must be >= to 18 years of age
- For recruitment at Adelphi University: Speak English
- For recruitment at Queens Hospital Center: Speak English
- For recruitment at Queens Hospital Center: Must be a Queens Hospital Center Patient
Key exclusion criteria (2 listed)
- Patients who have a history of colorectal cancer at the Queens Hospital Center
- Patients who cannot give informed consent
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Interviews45-minute individual interviews after the conclusion of their dental appointment | Behavioural | 1 |
| focus groupA focus group of the preliminary cancer-related risk perception item pool. | Behavioural | 2 |
| SurveyQuantitative item analysis of the final item pool. | Behavioural | 3 |
| SurveyA second confirmatory factor analysis. | Behavioural | 4 |
Primary outcome
Develop a comprehensive "blueprint," or description of the cancer-related risk perception construct; to use it to generate a cancer-related risk perception item pool; conduct an analysis of the generated items
Time frame: 3 years
1 secondary outcome
to establish initial evidence for scale reliability and validity
Time frame: 3 years
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Sep 2022.
- Memorial Sloan-Kettering web siteLink provided by the sponsor.
Related trials for Cancer Related-Risks
RecruitingPhase 1
IL-17 Blockade to Decrease irAEs (REPLAY)
Metastatic Melanoma
RecruitingPhase 2
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Not yet recruitingPhase 2
The CARDIOPROTECT Trial
Diffuse Large B-cell Lymphoma (DLBCL), Cardiotoxicity
Active, not recruiting
Eat, Move, Live Program for the Reduction of Cancer and Chronic Disease Risk in Underserved Communities
Diabetes Mellitus, Obesity-Related Malignant Neoplasm
Active, not recruitingPhase 2
De-Escalation Radiotherapy in Patients With Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma
Oropharyngeal Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jennifer L Hay, PhD principal investigator
Memorial Sloan Kettering Cancer Center
4 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cancer Related-Risks and Risk Perception, run by Memorial Sloan Kettering Cancer Center at 4 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Sep 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 4 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Develop a comprehensive "blueprint," or description of the cancer-related risk perception construct; to use it to generate a cancer-related risk perception item pool; conduct an analysis of the generated items (time frame: 3 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2022.